Drag a card by its title · ⚙ to size, swap or remove

The company

Pyxis Oncology, Inc.

PYXS · Nasdaq

Health CareBiotechnologyNot moving yet

PYXS stood above a rising 150-day average in 15 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 28.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 3
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $214K
Officials’ trades on record: 0
Institutions holding: 75 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 15 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1

Sale orders, 12 months1

Buyers · sellers1 · 1

Who	Did	Shares	Traded
Gordonmd Global Investments Lp10% owner	bought	5,517,000	1 Oct 2026filed 2 Oct 2026
Gordonmd Global Investments Lp10% owner	bought	7,546,766	1 Oct 2026filed 2 Oct 2026
Gordonmd Global Investments Lp10% owner	bought	7,172,000	1 Oct 2026filed 9 Oct 2026
Jakob DupontDirector	sold	35,000at $3.06	30 Jun 2026filed 2 Jul 2026
Rachel HumphreyDirector	sold	13,896at $1.03	21 Apr 2025filed 25 Mar 2026
Rachel HumphreyDirector	sold	200at $0.97	17 Apr 2025filed 25 Mar 2026
Rachel HumphreyDirector	sold	1,400at $0.9727	14 Apr 2025filed 25 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders75+2 on the quarter

New · exited12 · 11

Reported value$100.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
GordonMD Global Investments LPadded · filed 14 Aug 2026	10,024,909$30.2M	+5,903,039+143.2%
Pfizer Incunchanged · filed 13 Aug 2026	7,032,770$19.5M	00.0%
Laurion Capital Management LPreduced · filed 13 Aug 2026	4,900,888$14.8M	-96,445−1.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	2,075,997$6.2M	+42,487+2.1%
Atle Fund Management ABadded · filed 24 Jul 2026	966,459$2.9M	+769,423+390.5%
BlackRock, Inc.added · filed 7 Aug 2026	867,934$2.6M	+79,095+10.0%
Palo Alto Investors LPreduced · filed 17 Aug 2026	864,277$2.6M	-146,233−14.5%
MARSHALL WACE, LLPadded · filed 13 Aug 2026	830,544$2.5M	+476,127+134.3%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026	772,232$2.3M	-116,448−13.1%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	591,849$1.8M	-6,272−1.0%